Sandoz to acquire GSK’s cephalosporin antibiotics business for $500m
Sandoz, a division of the Swiss pharmaceutical giant Novartis, has finalized a deal to acquire the cephalosporin antibiotics business from GSK (GlaxoSmithKline) for up to ... Read More
Servier Laboratories to acquire Shire’s oncology business for $2.4bn
In a strategic move to expand its global presence, French pharmaceutical giant Servier Laboratories has announced a $2.4 billion all-cash acquisition of the oncology business ... Read More